ATE534387T1 - Hexahydro-cycloheptapyrazol-cannabinoid- modulatoren - Google Patents
Hexahydro-cycloheptapyrazol-cannabinoid- modulatorenInfo
- Publication number
- ATE534387T1 ATE534387T1 AT06814802T AT06814802T ATE534387T1 AT E534387 T1 ATE534387 T1 AT E534387T1 AT 06814802 T AT06814802 T AT 06814802T AT 06814802 T AT06814802 T AT 06814802T AT E534387 T1 ATE534387 T1 AT E534387T1
- Authority
- AT
- Austria
- Prior art keywords
- hexahydro
- cycloheptapyrazole
- cannabinoid modulators
- cycloheptapyrazole cannabinoid
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72025305P | 2005-09-23 | 2005-09-23 | |
| PCT/US2006/036158 WO2007038036A1 (en) | 2005-09-23 | 2006-09-18 | Hexahydro-cycloheptapyrazole cannabinoid modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE534387T1 true ATE534387T1 (de) | 2011-12-15 |
Family
ID=37635790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06814802T ATE534387T1 (de) | 2005-09-23 | 2006-09-18 | Hexahydro-cycloheptapyrazol-cannabinoid- modulatoren |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070123578A1 (de) |
| EP (1) | EP1937259B1 (de) |
| JP (1) | JP2009508953A (de) |
| KR (1) | KR20080050522A (de) |
| CN (1) | CN101312726A (de) |
| AT (1) | ATE534387T1 (de) |
| AU (1) | AU2006295121B2 (de) |
| BR (1) | BRPI0616402A2 (de) |
| CA (1) | CA2623745A1 (de) |
| CR (1) | CR9917A (de) |
| CY (1) | CY1112426T1 (de) |
| DK (1) | DK1937259T3 (de) |
| EA (1) | EA200800890A1 (de) |
| EC (1) | ECSP088314A (de) |
| ES (1) | ES2375213T3 (de) |
| HR (1) | HRP20120159T1 (de) |
| IL (1) | IL190347A0 (de) |
| NO (1) | NO20081948L (de) |
| PL (1) | PL1937259T3 (de) |
| PT (1) | PT1937259E (de) |
| RS (1) | RS52195B (de) |
| SI (1) | SI1937259T1 (de) |
| WO (1) | WO2007038036A1 (de) |
| ZA (1) | ZA200803532B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8378096B2 (en) | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
| US8378117B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
| JP2010522181A (ja) * | 2007-03-21 | 2010-07-01 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｃｂ２受容体介在疼痛を処置する方法 |
| JP6062633B2 (ja) * | 2009-01-28 | 2017-01-18 | カラ セラピューティクス インコーポレイテッド | 二環式ピラゾロ複素環類 |
| GB201706102D0 (en) * | 2017-04-18 | 2017-05-31 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2948718A (en) * | 1960-08-09 | New n-heterocyclic compounds | ||
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| AR227521A1 (es) * | 1979-06-01 | 1982-11-15 | Wellcome Found | Procedimiento para la preparacion de derivados de 3,5-diamino-6-(fenil substituido)-1,2,4-triazinas e intermediario para realizar el procedimiento |
| LU83729A1 (fr) * | 1981-11-04 | 1983-09-01 | Galephar | Sels d'acide valproique,leur preparation et leur utilisation |
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US5242942A (en) * | 1992-04-28 | 1993-09-07 | Mcneilab, Inc. | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| US5384327A (en) * | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
| FR2800375B1 (fr) * | 1999-11-03 | 2004-07-23 | Sanofi Synthelabo | Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant |
| FR2800372B1 (fr) * | 1999-11-03 | 2001-12-07 | Sanofi Synthelabo | Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant |
| WO2005063241A1 (ja) * | 2003-12-26 | 2005-07-14 | Ono Pharmaceutical Co., Ltd. | ミトコンドリアベンゾジアゼピン受容体介在性疾患の予防および／または治療剤 |
| BRPI0509207A (pt) * | 2004-03-24 | 2007-08-28 | Janssen Pharmaceutica Nv | moduladores canabinóides de tetraidro-indazol |
| FR2875230A1 (fr) * | 2004-09-13 | 2006-03-17 | Sanofi Aventis Sa | Derives de pyrazole condense, leur preparation et leur application en therapeutique |
-
2006
- 2006-09-18 EP EP06814802A patent/EP1937259B1/de active Active
- 2006-09-18 AT AT06814802T patent/ATE534387T1/de active
- 2006-09-18 RS RS20120064A patent/RS52195B/sr unknown
- 2006-09-18 DK DK06814802.2T patent/DK1937259T3/da active
- 2006-09-18 EA EA200800890A patent/EA200800890A1/ru unknown
- 2006-09-18 ES ES06814802T patent/ES2375213T3/es active Active
- 2006-09-18 US US11/522,771 patent/US20070123578A1/en not_active Abandoned
- 2006-09-18 BR BRPI0616402-1A patent/BRPI0616402A2/pt not_active Application Discontinuation
- 2006-09-18 AU AU2006295121A patent/AU2006295121B2/en not_active Ceased
- 2006-09-18 WO PCT/US2006/036158 patent/WO2007038036A1/en not_active Ceased
- 2006-09-18 KR KR1020087009625A patent/KR20080050522A/ko not_active Withdrawn
- 2006-09-18 HR HR20120159T patent/HRP20120159T1/hr unknown
- 2006-09-18 SI SI200631246T patent/SI1937259T1/sl unknown
- 2006-09-18 CN CNA200680043569XA patent/CN101312726A/zh active Pending
- 2006-09-18 CA CA002623745A patent/CA2623745A1/en not_active Abandoned
- 2006-09-18 PL PL06814802T patent/PL1937259T3/pl unknown
- 2006-09-18 PT PT06814802T patent/PT1937259E/pt unknown
- 2006-09-18 JP JP2008532297A patent/JP2009508953A/ja active Pending
-
2008
- 2008-03-20 IL IL190347A patent/IL190347A0/en unknown
- 2008-03-26 EC EC2008008314A patent/ECSP088314A/es unknown
- 2008-04-22 ZA ZA200803532A patent/ZA200803532B/xx unknown
- 2008-04-23 CR CR9917A patent/CR9917A/es not_active Application Discontinuation
- 2008-04-23 NO NO20081948A patent/NO20081948L/no not_active Application Discontinuation
-
2012
- 2012-02-09 CY CY20121100138T patent/CY1112426T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1937259B1 (de) | 2011-11-23 |
| ZA200803532B (en) | 2009-09-30 |
| BRPI0616402A2 (pt) | 2011-06-21 |
| IL190347A0 (en) | 2009-09-22 |
| ES2375213T3 (es) | 2012-02-27 |
| ECSP088314A (es) | 2008-04-28 |
| KR20080050522A (ko) | 2008-06-05 |
| AU2006295121B2 (en) | 2011-10-27 |
| HRP20120159T1 (hr) | 2012-03-31 |
| JP2009508953A (ja) | 2009-03-05 |
| CA2623745A1 (en) | 2007-04-05 |
| EA200800890A1 (ru) | 2009-02-27 |
| CR9917A (es) | 2008-09-09 |
| EP1937259A1 (de) | 2008-07-02 |
| SI1937259T1 (sl) | 2012-02-29 |
| PL1937259T3 (pl) | 2012-04-30 |
| DK1937259T3 (da) | 2012-02-13 |
| AU2006295121A1 (en) | 2007-04-05 |
| PT1937259E (pt) | 2012-01-17 |
| CY1112426T1 (el) | 2015-12-09 |
| US20070123578A1 (en) | 2007-05-31 |
| NO20081948L (no) | 2008-06-20 |
| CN101312726A (zh) | 2008-11-26 |
| WO2007038036A1 (en) | 2007-04-05 |
| RS52195B (sr) | 2012-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200602324A (en) | Tetrahydro-indazole cannabinoid modulators cross reference to related applications | |
| ZA200803533B (en) | Hexahydro cyclooctyl pyrazole cannabinoid modulators | |
| ECSP088316A (es) | Moduladores sustituidos de 3-amido-tetrahidro-indazolil cannabinoide | |
| BRPI0517378A (pt) | moduladores de tetraidro piridinil pirazol canabinóide | |
| MX2010001714A (es) | Moduladores de canabinoides 5-vinilfenil-1-fenil-pirazol sustituidos. | |
| NO20082505L (no) | Substtuert 5-heteroaryl-1-fenyl-pyrazol-cannabinoid-modulatorer | |
| ATE466854T1 (de) | 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren | |
| UA98487C2 (en) | Hexahydro-cycloheptapyrazole cannabinoid modulators | |
| ZA200803532B (en) | Hexahydro-cycloheptapyrazole cannabinoid modulators | |
| EA200601267A1 (ru) | Модуляторы рецепторов андрогена | |
| MX2009010159A (es) | Moduladores de cannabinoides hexahidro-ciclooctil pirazol. | |
| CR9479A (es) | Moduladores canabinoides de tetrahidrotiopirano pirazol | |
| UY30972A1 (es) | Moduladores cannabinoides hexahidro-ciclooctilpirazol | |
| UY30971A1 (es) | Moduladores cannabinoides hexahidro-cicloheptapirazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1937259 Country of ref document: EP |